Columbia St. Marys Cancer Center

Milwaukee, Wisconsin 53211

0 studies enrolling now · 6 studies all time

What they study most

Anal Cancer, B-Cell Chronic Lymphocytic Leukemia, Breast Cancer, Breast Tumor, Cancer of the Breast, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer, Progesterone Receptor- Negative Breast Cancer

Studies at this site

• Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer — Completed
• NBRST: Prospective Neo-adjuvant REGISTRY Trial — Completed
• Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) — Completed
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) — Completed
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — Completed
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer — Completed